rotenone

rotenone is a lipid of Polyketides (PK) class. Rotenone is associated with abnormalities such as Parkinson Disease, MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET, Neurodegenerative Disorders, Septicemia and Respiratory Failure. The involved functions are known as Phosphorylation, Process, Cell Death, proteasome activity and Apoptosis. Rotenone often locates in Protoplasm, Presynaptic Terminals, Neurites, NADH dehydrogenase complex and Mitochondria. The associated genes with rotenone are DNAJB9 gene, EIF2S3 gene, Candidate Disease Gene, G-substrate and ERN1 gene. The related lipids are Lipopolysaccharides, Membrane Lipids, Phosphatidylserines, Fatty Acids and Cardiolipins. The related experimental models are Knock-out, Mouse Model, Disease model and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of rotenone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with rotenone?

rotenone is suspected in Parkinson Disease, Ischemia, Parkinsonian Disorders, Renal tubular disorder, Morphologically altered structure, Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with rotenone

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Per page 10 20 50 100 | Total 87

PubChem Associated disorders and diseases

What pathways are associated with rotenone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with rotenone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with rotenone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with rotenone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with rotenone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with rotenone?

Knock-out

Knock-out are used in the study 'Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents.' (Revet I et al., 2011).

Mouse Model

Mouse Model are used in the study 'Inhibitors of metabolism rescue cell death in Huntington's disease models.' (Varma H et al., 2007) and Mouse Model are used in the study 'Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.' (Nair AS et al., 2006).

Rodent Model

Rodent Model are used in the study 'Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.' (Worth AJ et al., 2014) and Rodent Model are used in the study 'The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease.' (Hwang RD et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with rotenone

Download all related citations
Per page 10 20 50 100 | Total 3666
Authors Title Published Journal PubMed Link
Chiu CC et al. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism. 2015 Exp. Neurol. pmid:25263579
Calandria JM et al. The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease. 2015 Cell. Mol. Neurobiol. pmid:26047923
Qin J et al. Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease. 2015 Toxicol. Lett. pmid:26276080
Liang Y et al. Rifampicin attenuates rotenone-induced inflammation via suppressing NLRP3 inflammasome activation in microglia. 2015 Brain Res. pmid:26086368
Singh AK et al. Pyrroloquinoline quinone (PQQ) producing Escherichia coli Nissle 1917 (EcN) alleviates age associated oxidative stress and hyperlipidemia, and improves mitochondrial function in ageing rats. 2015 Exp. Gerontol. pmid:25843018
Fan F et al. Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. 2015 Toxicol. Sci. pmid:25752796
Liang S et al. GAPDH-knockdown reduce rotenone-induced H9C2 cells death via autophagy and anti-oxidative stress pathway. 2015 Toxicol. Lett. pmid:25725130
Khalil WK et al. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. 2015 Neurochem. Int. pmid:25481089
Nassar NN et al. Saxagliptin: a novel antiparkinsonian approach. 2015 Neuropharmacology pmid:25446674
Tyurina YY et al. LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease. 2015 Free Radic. Res. pmid:25740198
Yuan YH et al. The molecular mechanism of rotenone-induced α-synuclein aggregation: emphasizing the role of the calcium/GSK3β pathway. 2015 Toxicol. Lett. pmid:25433145
Mattam U and Jagota A Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson's disease male Wistar rat model and effect of melatonin administration. 2015 Biogerontology pmid:25430725
Belskie KM et al. Reverse electron transport effects on NADH formation and metmyoglobin reduction. 2015 Meat Sci. pmid:25828162
Sasajima H et al. Intranasal administration of rotenone in mice attenuated olfactory functions through the lesion of dopaminergic neurons in the olfactory bulb. 2015 Neurotoxicology pmid:26493152
Guo J et al. L10P mutation in DJ-1 gene induced oxidative stress and mitochondrial disfunction. 2015 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:26739068
Zhang Y et al. Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease. 2015 Sci Rep pmid:26207612
Zharikov AD et al. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. 2015 J. Clin. Invest. pmid:26075822
Hou YS et al. Sestrin2 Protects Dopaminergic Cells against Rotenone Toxicity through AMPK-Dependent Autophagy Activation. 2015 Mol. Cell. Biol. pmid:26031332
Feng Y et al. Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells. 2015 J. Neurochem. pmid:25991017
Worth AJ et al. Rotenone Stereospecifically Increases (S)-2-Hydroxyglutarate in SH-SY5Y Neuronal Cells. 2015 Chem. Res. Toxicol. pmid:25800467
Parameshwaran K et al. Antioxidant-mediated reversal of oxidative damage in mouse modeling of complex I inhibition. 2015 Drug Dev. Res. pmid:25847731
Zhao H et al. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement. 2015 Int J Clin Exp Pathol pmid:26884827
Ulbrich F et al. Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4. 2015 PLoS ONE pmid:26624894
Hou L et al. Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement. 2015 BMC Neurosci pmid:26608648
Johnson ME et al. Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease. 2015 J. Chem. Neuroanat. pmid:26562783
Liu LF et al. Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson's disease. 2015 Sci Rep pmid:26578166
Mailloux RJ et al. Superoxide produced in the matrix of mitochondria enhances methylmercury toxicity in human neuroblastoma cells. 2015 Toxicol. Appl. Pharmacol. pmid:26545714
Dalu T et al. An Assessment of the Effect of Rotenone on Selected Non-Target Aquatic Fauna. 2015 PLoS ONE pmid:26540301
Nayak M and Kim I Alkyne Carbonyl Metathesis As a Means To Make 4-Acyl Chromenes: Syntheses of (±)-Deguelin and (±)-Munduserone. 2015 J. Org. Chem. pmid:26525067
Bundela S et al. Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine. 2015 PLoS ONE pmid:26536350
Forkink M et al. Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells. 2015 Redox Biol pmid:26516986
Pellegrini C et al. Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence. 2015 Parkinsonism Relat. Disord. pmid:26499757
Ojha S et al. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease. 2015 Drug Des Devel Ther pmid:26504373
Ding W et al. Rotenone Attenuates Renal Injury in Aldosterone-Infused Rats by Inhibiting Oxidative Stress, Mitochondrial Dysfunction, and Inflammasome Activation. 2015 Med. Sci. Monit. pmid:26474533
Henrich CJ et al. Deguelins, Natural Product Modulators of NF1-Defective Astrocytoma Cell Growth Identified by High-Throughput Screening of Partially Purified Natural Product Extracts. 2015 J. Nat. Prod. pmid:26467198
Radad K et al. Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. 2015 Folia Neuropathol pmid:26443316
Won JH et al. Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation. 2015 J. Biol. Chem. pmid:26416893
Kim HS et al. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors. 2015 Eur J Med Chem pmid:26457742
Jung SY et al. Bee Venom Protects against Rotenone-Induced Cell Death in NSC34 Motor Neuron Cells. 2015 Toxins (Basel) pmid:26402700
Xia N et al. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model. 2015 Free Radic. Biol. Med. pmid:26454081
Kabiraj P et al. The neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cells. 2015 Protein J. pmid:26385697
Araujo SM et al. Effectiveness of γ-oryzanol in reducing neuromotor deficits, dopamine depletion and oxidative stress in a Drosophila melanogaster model of Parkinson's disease induced by rotenone. 2015 Neurotoxicology pmid:26366809
Griffiths LA and Flatters SJ Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy. 2015 J Pain pmid:26142652
Satish Bollimpelli V and Kondapi AK Differential sensitivity of immature and mature ventral mesencephalic neurons to rotenone induced neurotoxicity in vitro. 2015 Toxicol In Vitro pmid:26363201
Hawong HY et al. Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons. 2015 Brain Res. pmid:26141374
Liu B et al. Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson's disease. 2015 Brain Res. pmid:26342896
Garcia-Belinchón M et al. An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death. 2015 J. Biol. Chem. pmid:26124276
Syromyatnikov MY et al. Production of reactive oxygen species by flight muscle mitochondria of the bumblebee (Bombus terrestris L.). 2015 Dokl. Biochem. Biophys. pmid:26335818
Wang X et al. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7. 2015 Drug Des Devel Ther pmid:26089639
Sarkar S et al. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine. 2015 Neurosci. Lett. pmid:26321151
Nguyen MP et al. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion. 2015 Oncotarget pmid:26078334
Baba Y et al. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines. 2015 Biomed Res Int pmid:26075254
Lee SC et al. Synthesis and Evaluation of a Novel Deguelin Derivative, L80, which Disrupts ATP Binding to the C-terminal Domain of Heat Shock Protein 90. 2015 Mol. Pharmacol. pmid:25976766
Meinel J et al. Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. 2015 Folia Neuropathol pmid:25909873
Slone SR et al. Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins. 2015 Neurobiol. Dis. pmid:25862939
Wells RG et al. Flow-Dependent Uptake of ¹²³I-CMICE-013, a Novel SPECT Perfusion Agent, Compared with Standard Tracers. 2015 J. Nucl. Med. pmid:25840976
Grefte S et al. Rotenone inhibits primary murine myotube formation via Raf-1 and ROCK2. 2015 Biochim. Biophys. Acta pmid:25827955
Deheshi S et al. Changes in mitochondrial morphology induced by calcium or rotenone in primary astrocytes occur predominantly through ros-mediated remodeling. 2015 J. Neurochem. pmid:25761412
Alkholifi FK and Albers DS Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination. 2015 Brain Res. pmid:26168893
Abdelsalam RM and Safar MM Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. 2015 J. Neurochem. pmid:25752913
Kim HK et al. The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells--The potential of JNX1001 as a therapeutic agent. 2015 Eur. J. Pharmacol. pmid:26164791
Nojima Y et al. Superoxide dismutases, SOD1 and SOD2, play a distinct role in the fat body during pupation in silkworm Bombyx mori. 2015 PLoS ONE pmid:25714339
Liang Y et al. Toxicity of amorphigenin from the seeds of Amorpha fruticosa against the larvae of Culex pipiens pallens (Diptera: Culicidae). 2015 Molecules pmid:25690287
Xu Q et al. Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation. 2015 Breast Cancer Res. Treat. pmid:25677747
Zhang Z et al. Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone-induced Parkinson's disease rats. 2015 Eur. J. Neurosci. pmid:26153521
Yin L et al. The S-nitrosylation status of PCNA localized in cytosol impacts the apoptotic pathway in a Parkinson's disease paradigm. 2015 PLoS ONE pmid:25675097
Hsu CC et al. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs. 2015 Oncol. Rep. pmid:26133123
Goldstein DS et al. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease. 2015 J. Neurochem. pmid:25645689
Goswami P et al. Astrocyte activation and neurotoxicity: A study in different rat brain regions and in rat C6 astroglial cells. 2015 Environ. Toxicol. Pharmacol. pmid:26113375
Singh K et al. NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells. 2015 Biochim. Biophys. Acta pmid:25639646
Chioua M et al. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease. 2015 Future Med Chem pmid:26061104
Tiernan CT et al. Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase. 2015 Toxicol. Sci. pmid:25601988
Verma DK et al. Metabolic enhancer piracetam attenuates rotenone induced oxidative stress: a study in different rat brain regions. 2015 Acta Neurobiol Exp (Wars) pmid:26994419
Mena NP et al. The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death. 2015 Biochem. Biophys. Res. Commun. pmid:26051278
Rohan M et al. Using gamma distribution to determine half-life of rotenone, applied in freshwater. 2015 Sci. Total Environ. pmid:25965037
Melo KM et al. Short-term exposure to low doses of rotenone induces developmental, biochemical, behavioral, and histological changes in fish. 2015 Environ Sci Pollut Res Int pmid:25948382
Lee S et al. Total synthesis of (-)-deguelin via an iterative pyran-ring formation strategy. 2015 Chem. Commun. (Camb.) pmid:25940751
Tan Z et al. Nesfatin-1 antagonized rotenone-induced neurotoxicity in MES23.5 dopaminergic cells. 2015 Peptides pmid:25937598
Hrynevich SV et al. Influence of Glucose Deprivation on Membrane Potentials of Plasma Membranes, Mitochondria and Synaptic Vesicles in Rat Brain Synaptosomes. 2015 Neurochem. Res. pmid:25894686
Murakami S et al. Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice. 2015 Neurochem. Res. pmid:25894684
Cappelletti G et al. Linking microtubules to Parkinson's disease: the case of parkin. 2015 Biochem. Soc. Trans. pmid:25849932
Hsu CG and Burkholder TJ Activation of p38 in C2C12 myotubes following ATP depletion depends on extracellular glucose. 2015 J. Physiol. Biochem. pmid:25835326
Hong Y et al. NAD+ treatment can prevent rotenone-induced increases in DNA damage, Bax levels and nuclear translocation of apoptosis-inducing factor in differentiated PC12 cells. 2015 Neurochem. Res. pmid:25813492
Milowska K et al. Carbosilane dendrimers inhibit α-synuclein fibrillation and prevent cells from rotenone-induced damage. 2015 Int J Pharm pmid:25735664
Cabezas R et al. PDGF-BB protects mitochondria from rotenone in T98G cells. 2015 Neurotox Res pmid:25516121
Lagido C et al. A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans. 2015 J Vis Exp pmid:26554627
Johnson ME and Bobrovskaya L An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. 2015 Neurotoxicology pmid:25514659
Lee I Betaine is a positive regulator of mitochondrial respiration. 2015 Biochem. Biophys. Res. Commun. pmid:25498545
ErbaÅŸ O et al. The neuroprotective effect of erythropoietin on experimental Parkinson model in rats. 2015 Neuropeptides pmid:25464888
Bae N et al. Neuroprotective effect of modified Chungsimyeolda-tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson's disease. 2015 J Ethnopharmacol pmid:25449460
Maturana MG et al. Unveiling the role of the pesticides paraquat and rotenone on α-synuclein fibrillation in vitro. 2015 Neurotoxicology pmid:25447323
von Wrangel C et al. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings. 2015 Behav. Brain Res. pmid:25446762
Wu F et al. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease. 2015 Neuroscience pmid:25446361
Ferreira IL et al. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release. 2015 Neurobiol. Aging pmid:25442114
Gielisch I and Meierhofer D Metabolome and proteome profiling of complex I deficiency induced by rotenone. 2015 J. Proteome Res. pmid:25361611
Nascimento C et al. Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction. 2015 J Neural Transm (Vienna) pmid:25261015
Yi S et al. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation. 2015 Ann. Hematol. pmid:25242579
Rashed ER et al. Potential efficacy of dopamine loaded-PVP/PAA nanogel in experimental models of Parkinsonism: possible disease modifying activity. 2015 J Biomed Mater Res A pmid:25131611
Plaza Dávila M et al. Epigallocatechin-3-Gallate (EGCG) Reduces Rotenone Effect on Stallion Sperm-Zona Pellucida Heterologous Binding. 2015 Reprod. Domest. Anim. pmid:26482419
Thakur P and Nehru B Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson's disease. 2015 Mol. Neurobiol. pmid:24946750